Printed From BioPortfolio.com
Pilot study shows fluorescent imaging with antibody safely used in glioblastoma patients
13:39 EDT 25 Oct 2017 | ecancermedicalscience
In its first test in humans, the antibody cetuximab proved to be safe and feasible for infrared fluorescent imaging of tumours during brain surgery. The study is the first to show that the antibody-based infrared fluorescent imaging can specifically...
Original Article: Pilot study shows fluorescent imaging with antibody safely used in glioblastoma patients
